22nd Apr 2015 07:23
LONDON (Alliance News) - Deltex Medical Group PLC Wednesday said it has established its ninth dedicated trainer account in the US, sending shares in the company higher in early trade.
Deltex said the account has been secured with an unnamed "highly prestigious teaching hospital" based in Boston, Massachusetts. The hospital has now approved the purchase of at least 500 CardioQ-ODM+ oesophageal Doppler monitoring devices in its 2015-16 budget, which starts in October.
In the interim, the hospital is buying probes on an ad hoc basis and has placed three orders of 50 probes apiece over the past four months.
Deltex did not provide any financial details on the deal.
"This is the third new dedicated trainer account established this year and the ninth in total. It is another key step towards our strategy of building, by mid-2016, a strong platform for future national roll-out of ODM in the key US market," said Deltex Chief Executive Ewan Phillips.
Deltex makes oesophageal Doppler monitoring technology. The monitoring systems are used to measure blood flow during surgery by generating a low-frequency ultrasound signal and utilising the Doppler effect. The Doppler effect is the change in frequency of a wave for an observer moving relative to its source, such as the way in which the noise of a siren changes when it passes by.
The company sends dedicated trainers into hospitals to help train physicians in using its technology.
It had won its eighth dedicated trainer account earlier this month and its seventh back in January, after winning previous accounts in June and January of last year.
Shares in Deltex were up 11% to 5.4 pence in early trade, one of the best performers in the AIM All-Share index.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical